Just hope the market looks at the potential and not the financials Massive loss but it is still early stage in developing treatments Good for top up if it drops
Guys just look at avacta yesterday Sng also operates at a loss and on its own the price would have dropped but it is really nice to release it with the MAP rns Ensure we stay on course for steady progress
guys i think we need some balance: I am invested here too and it fantastic prospects but financially the company is still early stage and that is reflected in the final results earlier this year - operating at a huge loss and then needing a placement in July around £8M.